Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

UE LifeSciences Inc.

Facebook Twitter LinkedIn Email Comments
Medical device manufacturer UE LifeSciences Inc. of Philadelphia received market clearance from the FDA for its NoTouch BreastScan device. The contact-free breast-imaging tool was cleared by the FDA specifically for adjunctive diagnostic screening for breast cancer. The imaging system incorporates patent-pending dual-infrared detector design. The company says the tool dynamically analyzes temperature pixels from various infrared frames to create a real-time objective report for the physician. UE plans to offer NoTouch BreastScan services to clinics in the US beginning in the New York, New Jersey and Pennsylvania regions.

BioPhotonics
May 2012
AmericasBiophotonicsbreast cancer detectionbreast cancer screeningbreast imagingBusinessdiagnostic screening breast cancerearly breast cancerFDAimaginginfrared imaging system breast cancerNew JerseyNew YorkNoTouch BreastScanPennsylvaniaRapidScanSensors & DetectorsUE LifeSciencesUS Food and Drug Administration

Comments
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.